Therapeutic Dog Food Market to hit USD 8,949.52 Million, Globally, by 2028 at 5.6% CAGR: The Insight Partners

The therapeutic dog food market is projected to reach US$ 8,949.52 million by 2028 from US$ 6,095.70 million in 2021; it is estimated to grow at a CAGR of 5.6% from 2021 to 2028.

The report highlights the market trends, drivers, and deterrents. The increasing adoption of dogs for companionship, growing prevalence of chronic diseases among dogs, and surge in launch of therapeutic dog food products drive the market growth. However, low sales in developing countries hampers the market growth.

Therapeutic dog food is specifically formulated to aid in the management of various illnesses and diseases. These diets are also prescribed in the treatment of itchy skin, digestive issues, obesity, allergies, and heat diseases, among others. Pet food manufacturers are increasingly changing their product variants, making them suitable for the wellness of pets.

Get Sample PDF Copy of Therapeutic Dog Food Market at: https://www.theinsightpartners.com/sample/TIPRE00023444/?utm_source=OpenPR&utm_medium=10408

Based on product type, the global therapeutic dog food market is segmented into dry food, wet/canned food, snacks/treats, and others. In 2020, the dry food segment held the largest share of the market. Furthermore, the snacks/treats segment is expected to register the highest CAGR in the market during 2021-2028. Dry foods are perceived beneficial to their dental health. In some cases, they can decrease calculus (tartar). The choice of dry or canned foods is based on pet owner preferences and perhaps cost, unless the pet requires higher fluid intake (like cats with chronic kidney disease or pets with urinary stones) dogs which is expected to drive the market during the forecast period.

Market Insights
Increasing Adoption of Dogs for Companionship to drive Therapeutic Dog Food market growth
Dogs are considered an apt companion for humans as they have a significant impact on their owner's life. They promote an active lifestyle and can detect oncoming epileptic seizures much before the actual incidence. Pets help bring social, emotional, and cognitive development in children, in addition to helping adults in relieving stress and anxiety. Research studies have shown that dog owners are at 36% lower risk of dying from cardiovascular disease and 11% lower risk of getting a heart attack. As per the American Pet Products Association's 2019-2020 survey, ~63.4 million households own at least one dog in the US. Also, as per the FEDIAF, the body representing
European pet food industry, the popularity of dogs is growing in the region; the count of pet dogs in the EU rose from 63.7 million in 2016 to 66.4 million in 2017. According to the Animal Wellbeing (PAW) Report 2019 by the People's Dispensary for Sick Animals (PDSA), ~50% of the UK population owns a pet, with an estimated population of 9.9 million pet dogs. 26% of adults in the country own a dog. Thus, a surging preference for dogs as a companion is fueling the therapeutic dog food market growth.

Growing Prevalence of Chronic Diseases Among Dogs Contribute Significantly to Therapeutic Dog Food Market Growth
Similar to humans, animals too suffer from chronic diseases. Arthritis, chronic kidney disease, cancer, hepatitis and other liver diseases, skin allergies, and diabetes are commonly detected chronic diseases in pets. Cancer is widespread in animals and affects dogs as well. According to the veterinary cancer society, the disease is a leading cause of death in 47% of dogs, especially dogs of age >10 years. Further, as per the Pet Cancer Facts and Figures, one in every four dogs develops cancer in its lifetime. According to the Association for Pet Obesity Prevention (APOP), ~55.8% of dogs in the US were overweight or obese in 2018. The Arthritis Foundation says ~20% of all adult dogs suffer from arthritis. Such a growing prevalence of chronic medical conditions has become a major concern among dog owners, which underlines the demand for proper care. Thus, with the elevating prevalence of chronic medical conditions in dogs, companies are focusing on offering advanced therapeutic food products to help dog owners in maintaining the overall health of their pets

Speak to Analyst for more details:
https://www.theinsightpartners.com/speak-to-analyst/TIPRE00023444?utm_source=OpenPR&utm_medium=10408

Therapeutic Dog Food Market: Competitive Landscape and Key Developments
Mars, Incorporated; Nestlé; Hill's Pet Nutrition, Inc.; The J. M. Smucker Company; GENERAL MILLS, INC.; ANIMONDA; DARWIN PET; SCHELL & KAMPETER, INC.; AFFINITY PETCARE S.A; Beaphar; and WellPet are among the key companies operating in the therapeutic dog food market.

As per the Insurance Research Council's October 2020 report, during the COVID-19, around 30% of Americans adopted a pet owing to increase in need for companionship. Furthermore, according to the German Kennel Club (VDH), ~20% more dogs were purchased in 2020 than the previous year. Most of the consumers in the market grappled with the onset of the pandemic. Retail and e-commerce platforms witnessed high growth due to several restrictions on the brick-and-mortar stores and the disruption of overall supply channels.? Several online retailers reported strong sales of pet products. For instance, Chewy.com witnessed accelerated sales since February 2020. The company generates ~70% of its sales through subscription customers. These conditions are offering lucrative opportunities for the growth of the therapeutic dog food market in the coming years.

Order a Copy of Therapeutic Dog Food Market Shares, Strategies and Forecasts 2021-2028 Research Report at: https://www.theinsightpartners.com/buy/TIPRE00023444/?utm_source=OpenPR&utm_medium=10408

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

This release was published on openPR.